Medical network - on July 13, not long ago, China's first "method of traditional Chinese medicine" formally implemented, presented a gift to industry of Chinese medicine, analysts say, it released a number of policy dividends, will lift development boom, impact on $one trillion of market of traditional Chinese medicine.
In fact, the Chinese market in 2016 did not. As the most representative of proprietary Chinese medicine, for example, the customs statistics show, proprietary Chinese medicine in China imported $2016 in 321 million, year-on-year growth of 10.57%, a sharp contrast, annual exports but not optimistic, exports was $225 million, fell 13.94% year on year. Poor potential obviously, what is the problem?
Transformation of strong international medicine will take time
According to China's pharmaceutical industry information center of CPM database statistics, at present, the world has been listed on the proprietary Chinese medicine with a total of four varieties, is "a handful". And by the state food and drug supervision and administration bureau (CFDA) approved production of proprietary Chinese medicine, a total of 9702 competition fierce.
Global proprietary Chinese medicine varieties already on the market
CFDA approve the import of proprietary Chinese medicine, on the other hand, there are 49, including 45 varieties in domestic has not been approved for domestic. Research and development of domestic gap still exists.
Chinese approval for import of proprietary Chinese medicine varieties
Uneven and dosage form development
From the point of dosage form distribution, the CFDA approval in the production of proprietary Chinese medicine, the top three in the capsule, tablet and pills appeared in the production of "heat" phenomenon, accounted for 20.1%, 16.4% and 14.9%, respectively, more than half of the total. While the rest of the varieties of dosage forms are mostly scattered, the market contains more opportunities.
Distribution of proprietary Chinese medicine formulations of domestic production approval
So, where is the development of proprietary Chinese medicine market to watch?
Market expansion is a big trend
In recent two years, total bureau of national food and drug supervision and administration of drug approval center (CDE) to accept the proprietary Chinese medicine clinical research, a total of 75 pieces. Every year to declare smooth trend, proprietary Chinese medicine market in the coming years is expected to still have a period of growth.
Note: scroll years, eight full quarter
A new drug
In CDE received proprietary Chinese medicine, including love ning emulsion injection, 56, a class of new drugs such as white dragon wine is most remarkable. Under the internationalization of Chinese medicine to speed up the climate, the high quality of innovative drugs must be rushed in front.
CDE to accept the proprietary Chinese medicine (a class of new drugs) view
Data sources: China's pharmaceutical industry information center CPM database
|
